Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
-
* Corresponding author: Nita J Maihle nita.maihle@yale.edu
Journal of Ovarian Research 2010, 3:7 doi:10.1186/1757-2215-3-7
No comments have yet been made on this article.